Processa Pharmaceuticals, Inc.
PCSACIK 0001533743 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0040
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Processa Pharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Yorke Justin W | Director | 17 |
| Stanker James H | Officer | 11 |
| Pannu Geraldine | Director | 10 |
| Skibsted Russell | Officer | 9 |
| Baluch Khoso | Director | 7 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Processa Pharmaceuticals, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Yorke Justin W | 3 | 33% | -21.5% | -22.2% | +19.3% | -61.6% |
| 2 | Young David | 8 | 50% | -11.1% | +1.5% | +15.0% | -61.6% |
| 3 | Lin Patrick | 7 | 14% | -4.5% | -7.9% | +72.5% | -61.6% |
All filings
180 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|